Lv3
400 积分 2023-09-13 加入
Opportunities and limitations of B cell depletion approaches in SLE
1个月前
已完结
4C:ARA18 | Deep Immunological Reset and Reversal of Fibrosis in Refractory Systemic Sclerosis: A Pilot Study of Tandem CD19-BCMA CAR-T Therapy
1个月前
已完结
Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases
4个月前
已完结
Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6
5个月前
已完结
BCMA CAR T-cell therapy in newly diagnosed primary plasma cell leukemia ineligible for transplantation: An open label, single-arm, phase 2 study (CAREMM-002)
6个月前
已关闭
Targeting IL-1α in cancer cachexia: a narrative review
7个月前
已完结
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
7个月前
已完结
Linvoseltamab (LINVO) + carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Initial results from the LINKER-MM2 trial
8个月前
已关闭
Pre-treatment with carfilzomib significantly improves response in R/R MM patients undergoing BCMA-directed CAR T cell therapy
8个月前
已关闭
皖公网安备34019202002308
